HEART FAILURE, SYSTOLIC
Clinical trials for HEART FAILURE, SYSTOLIC explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE, SYSTOLIC trials appear
Sign up with your email to follow new studies for HEART FAILURE, SYSTOLIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart failure drug enters first human safety trial
Disease control Not yet recruitingThis early-stage trial will test a single dose of a new drug called LY3971297 in 90 people with two types of heart failure: preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF). The main goal is to see if the drug is safe and what side effects occur. Particip…
Matched conditions: HEART FAILURE, SYSTOLIC
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a phone app replace cardiac rehab? a new trial puts digital heart care to the test
Disease control Not yet recruitingThis pilot study is testing whether a smartphone app called HeartMate can help people with heart disease manage their condition from home. Over six weeks, participants use the app for daily heart checks, guided exercise, breathing training, and a mind program, with weekly coachin…
Matched conditions: HEART FAILURE, SYSTOLIC
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Virtual heart team aims to close medication gap for veterans with heart failure
Disease control Not yet recruitingThis study tests whether a virtual team of clinical pharmacists and cardiologists can help doctors prescribe the right heart failure medications for Veterans. Many patients do not receive all recommended drugs at effective doses after a hospital stay. The team reviews patient rec…
Matched conditions: HEART FAILURE, SYSTOLIC
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC